Comprehensive analytics tool for forecasting breakthrough therapeutic technologies by integrating multi-dimensional data sources including clinical development pipelines, intellectual property landscapes, and capital mar.
50
55%
Does it follow best practices?
Run evals on this skill
Adds up to 20 points to the overall score
View guide
Passed
No findings from the security scan
Fix and improve this skill with Tessl
tessl review fix ./scientific-skills/Evidence Insight/blockbuster-therapy-predictor/SKILL.mdComprehensive analytics tool for forecasting breakthrough therapeutic technologies by integrating multi-dimensional data sources including clinical development pipelines, intellectual property landscapes, and capital market indicators.
See ## Features above for related details.
scripts/main.py.references/ for task-specific guidance.See ## Usage above for related details.
cd "20260318/scientific-skills/Evidence Insight/blockbuster-therapy-predictor"
python -m py_compile scripts/main.py
python scripts/main.py --helpExample run plan:
CONFIG block or documented parameters if the script uses fixed settings.python scripts/main.py with the validated inputs.See ## Workflow above for related details.
scripts/main.py.references/ contains supporting rules, prompts, or checklists.Use this command to verify that the packaged script entry point can be parsed before deeper execution.
python -m py_compile scripts/main.pyUse these concrete commands for validation. They are intentionally self-contained and avoid placeholder paths.
python -m py_compile scripts/main.py
python scripts/main.py --help# Run complete analysis with all technologies
python scripts/main.py
# Analyze specific technologies
python scripts/main.py --tech PROTAC,mRNA,CRISPR
# Output in JSON format
python scripts/main.py --output json| Parameter | Type | Default | Required | Description |
|---|---|---|---|---|
--mode | str | full | No | Analysis mode: full or quick |
--tech | str | None | No | Comma-separated list of technologies to analyze |
--output | str | console | No | Output format: console or json |
--threshold | float | 0 | No | Minimum blockbuster index threshold (0-100) |
--save | str | None | No | Save report to file path |
# Analyze high-potential technologies only (index ≥70)
python scripts/main.py \
--threshold 70 \
--output json \
--save high_potential_report.json
# Quick analysis of specific platforms
python scripts/main.py \
--mode quick \
--tech CAR-T,ADC,Bispecific \
--output console🏆 BLOCKBUSTER THERAPY PREDICTOR Report
Generated: 2026-02-15 10:30:00
Technologies analyzed: 10
📊 Technology Rankings
Rank Technology Blockbuster Index Maturity Market Potential Momentum Recommendation
🥇 1 mRNA 85.2 78.5 92.1 88.0 Strongly Recommended
🥈 2 CAR-T 82.3 85.2 78.5 75.0 Strongly Recommended
🥉 3 CRISPR 79.8 72.3 88.2 68.0 Recommended{
"generated_at": "2026-02-15T10:30:00",
"total_routes": 10,
"rankings": [
{
"rank": 1,
"tech_name": "mRNA",
"blockbuster_index": 85.2,
"maturity_score": 78.5,
"market_potential_score": 92.1,
"momentum_score": 88.0,
"recommendation": "Strongly Recommended",
"key_drivers": ["Multiple Phase III trials", "Rapid patent growth"],
"risk_factors": ["Regulatory uncertainties"],
"timeline_prediction": "First product expected in 2-4 years"
}
]
}Blockbuster Index = (Market Potential × 0.5) + (Maturity × 0.3) + (Momentum × 0.2)| Component | Weight | Factors |
|---|---|---|
| Market Potential | 50% | Market size, unmet need, competition |
| Maturity | 30% | Clinical stage, patent depth, funding stage |
| Momentum | 20% | Patent growth, funding activity, clinical progress |
| Blockbuster Index | Recommendation | Action |
|---|---|---|
| ≥ 80 | Strongly Recommended | Prioritize R&D investment |
| 60-79 | Recommended | Active monitoring and early partnerships |
| 40-59 | Watch | Monitor milestones; reassess in 6-12 months |
| < 40 | Cautious | Minimal investment; consider divestment |
| Technology | Category | Description |
|---|---|---|
| PROTAC | Protein Degradation | Proteolysis Targeting Chimera |
| mRNA | Nucleic Acid Drugs | Messenger RNA therapy platform |
| CRISPR | Gene Editing | CRISPR-Cas gene editing technology |
| CAR-T | Cell Therapy | Chimeric Antigen Receptor T-cell therapy |
| Bispecific | Antibody Drugs | Bispecific antibody technology |
| ADC | Antibody Drugs | Antibody-Drug Conjugate |
| RNAi | Nucleic Acid Drugs | RNA interference therapy |
| Gene Therapy | Gene Therapy | AAV vector gene therapy |
| Allogeneic | Cell Therapy | Universal/Allogeneic cell therapy |
| Cell Therapy | Cell Therapy | General cell therapy platform |
⚠️ AI independent acceptance status: manual inspection required This skill requires:
pip install -r requirements.txtdataclasses
enum| Risk Indicator | Assessment | Level |
|---|---|---|
| Code Execution | Python scripts executed locally | Medium |
| Network Access | No external API calls in mock mode | Low |
| File System Access | Read/write report files only | Low |
| Instruction Tampering | Standard prompt guidelines | Low |
| Data Exposure | Output files saved to workspace | Low |
# Python dependencies
pip install -r requirements.txtSee references/ for:
⚠️ DISCLAIMER: This tool provides quantitative analysis for decision support only. All investment and R&D decisions should incorporate qualitative domain expertise, regulatory consultation, and comprehensive due diligence. Past performance of historical blockbusters does not guarantee future success of emerging technologies.
Every final response should make these items explicit when they are relevant:
scripts/main.py fails, report the failure point, summarize what still can be completed safely, and provide a manual fallback.This skill accepts requests that match the documented purpose of blockbuster-therapy-predictor and include enough context to complete the workflow safely.
Do not continue the workflow when the request is out of scope, missing a critical input, or would require unsupported assumptions. Instead respond:
blockbuster-therapy-predictoronly handles its documented workflow. Please provide the missing required inputs or switch to a more suitable skill.
Use the following fixed structure for non-trivial requests:
If the request is simple, you may compress the structure, but still keep assumptions and limits explicit when they affect correctness.
63c61d3
If you maintain this skill, you can claim it as your own. Once claimed, you can manage eval scenarios, bundle related skills, attach documentation or rules, and ensure cross-agent compatibility.